{
  "meta": {
    "title": "32_Multiple_Myeloma_And_Plasma_Cell_Disorders",
    "url": "https://brainandscalpel.vercel.app/32-multiple-myeloma-and-plasma-cell-disorders-82683e64.html",
    "scrapedAt": "2025-11-30T12:33:37.398Z"
  },
  "questions": [
    {
      "text": "What is the normal ratio between kappa and lambda light chains?",
      "choices": [
        {
          "id": 1,
          "text": "70:30"
        },
        {
          "id": 2,
          "text": "60:40"
        },
        {
          "id": 3,
          "text": "40:60"
        },
        {
          "id": 4,
          "text": "30:70"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The<strong> normal ratio</strong> of kappa to lambda light chains is <strong>60:40</strong>.</p>\n<p>In multiple myeloma, usually this ratio is skewed, i.e.,&nbsp;favorable secretion of one type of light chain occurs at the expense of the&nbsp;other.&nbsp;Serum-free light chain assay is a recommended part of the initial diagnostic workup for multiple myeloma.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0210",
      "difficulty": "medium"
    },
    {
      "text": "Patients with which of the following can be classified under smoldering multiple myeloma?",
      "choices": [
        {
          "id": 1,
          "text": "Lack of symptoms and a high plasma M component with bone marrow plasma cells >10%"
        },
        {
          "id": 2,
          "text": "Plasma cells >10% in the bone marrow, no paraprotein in blood and presence of lytic bone lesions"
        },
        {
          "id": 3,
          "text": "Plasma cells >10% in bone marrow, abnormal serum free light chain ratio and hypercalcemia"
        },
        {
          "id": 4,
          "text": "Presence of symptoms and a low plasma M component with plasma cells <10%"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Smoldering multiple myeloma</strong> refers to an uncommon variant defined by a <strong>lack of symptoms</strong> and a<strong> high plasma M component.</strong></p>\n<p>The difference between MGUS, smouldering multiple myeloma, and multiple myeloma is given below:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>MGUS</strong></td>\n<td><strong>Smouldering&nbsp;multiple Myeloma</strong></td>\n<td><strong>Multiple Myeloma</strong></td>\n</tr>\n<tr>\n<td>Asymptomatic</td>\n<td>Asymptomatic</td>\n<td>Symptomatic</td>\n</tr>\n<tr>\n<td>M protein in serum&nbsp;&lt;3g/dL</td>\n<td>\n<p>M-protein in serum:</p>\n<ul>\n<li>IgG &ge;3 g/dL,</li>\n<li>IgA &gt;1 g/dL</li>\n</ul>\n</td>\n<td>M protein in serum and urine</td>\n</tr>\n<tr>\n<td>Bone Marrow (BM) plasma cells &lt;10%</td>\n<td>BM plasma cells 10-60%</td>\n<td>BM plasma cells &ge;60%</td>\n</tr>\n<tr>\n<td>No other organ or tissue impairment</td>\n<td>No other organ or tissue impairment</td>\n<td>Related impairment is seen.<br />(CRAB)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: WHO Classification of Plasma Cell Neoplasms</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Plasma cell neoplasms and variants</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>A. PLASMA CELL NEOPLASMS</strong></td>\n</tr>\n<tr>\n<td><strong> Multiple myeloma </strong>(previously plasma cell myeloma)</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Non secretory: No secretion of Ig, No M component</li>\n<li>Smoldering: M protein in serum ≥ 3g/dL and/or ≥10% clonal plasma cells in bone marrow, and no related organ or tissue impairment</li>\n<li>Plasma-cell leukemia: &gt;20% plasma cells in the peripheral blood or Absolute plasma cell count of &gt;2 X 109/L</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Plasmacytoma</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Solitary plasmacytoma: Localized tumour of monoclonal plasma cells with no clinical features of plasma cell myeloma</li>\n<li>Extramedullary(extraosseous) plasmacytoma: Localized plasma cell neoplasms that arise in tissues other than bone</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Plasma cell neoplasms with associated paraneoplastic syndrome </strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>POEMS syndrome- Polyneuropathy, organomegaly, Endocrinopathy, Monoclonal gammopathy, Skin changes</li>\n<li>TEMPI syndrome </li>\n<li>AESOP syndrome</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>B. MONOCLONAL IMMUNOGLOBULIN DEPOSITION DISEASES </strong></td>\n</tr>\n<tr>\n<td><strong>Immunoglobulin-related</strong> (AL) <strong>amyloidosis</strong> (previously primary amyloidosis)</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Systemic AL amyloidosis</li>\n<li>Localised AL amyloidosis</li>\n<li>Heavy chain amyloidosis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Monoclonal immunoglobulin deposition disease</strong> (previously light and heavy chain deposition disease)</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Light chain deposition disease</li>\n<li>Heavy chain deposition disease</li>\n<li>Light and heavy chain deposition disease</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>C. MONOCLONAL GAMMOPATHIES</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Cold agglutinin disease</li>\n<li>Monoclonal gammopathy of renal significance</li>\n<li>IgM and non-IgM monoclonal gammopathy of undetermined signifcance</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9420",
      "difficulty": "medium"
    },
    {
      "text": "A 76-year-old man presents for a routine health check-up and is found to be mildly anemic. Physical examination reveals no abnormalities. Serum protein electrophoresis with immunofixation demonstrates an IgG-kappa monoclonal protein with markedly reduced IgM and IgA levels. Bone marrow biopsy shows 12% plasma cells. A skeletal survey reveals osteopenia and several punched-out lytic lesions, but no fractures. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Plasma cell leukemia"
        },
        {
          "id": 2,
          "text": "Multiple myeloma"
        },
        {
          "id": 3,
          "text": "Plasmacytoma"
        },
        {
          "id": 4,
          "text": "MGUS"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of<strong>&nbsp;multiple myeloma</strong>.</p>\n<p>Plasma cell dyscrasias are B-cell proliferations that contain <strong>neoplastic plasma cells</strong> that secrete a monoclonal Ig or Ig fragment.&nbsp;Multiple myeloma is a malignant neoplasm of plasma cells characterized by the presence of <strong>monoclonal immunoglobulin or light chains </strong>in the serum and urine. It is a&nbsp;disease of older adults, with a peak age of incidence of 65 to 70 years.</p>\n<p>Signs and symptoms include:</p>\n<ul>\n<li>Hypercalcemia</li>\n<li>Pathologic fractures/ lytic bone lesions</li>\n<li>Renal failure</li>\n<li>Anemia</li>\n</ul>\n<p>Investigations reveal:</p>\n<ul>\n<li>Radiography -&nbsp;<strong>Punched-out lytic lesions</strong> on X-ray</li>\n<li>Electrophoresis -&nbsp;<strong>Monoclonal elevation </strong>of one immunoglobulin</li>\n<li>Urinalysis - Free <strong>kappa </strong>and<strong> lambda </strong>light chains (Bence Jones proteins)</li>\n<li>Bone marrow biopsy -&nbsp;<strong>10 to 20%</strong>plasma cells (normal is &lt; 5%)</li>\n<li>Peripheral smear -&nbsp;<strong>Rouleaux </strong>formation. A high level of M proteins in myeloma causes red cells in the peripheral blood smears to stick to one another in linear arrays, a finding referred to as <strong>rouleaux formation</strong>.</li>\n</ul>\n<p>Plasma cell tumors are positive for<strong> CD138.</strong></p><hr><h3>Related Pearl: WHO Classification of Plasma Cell Neoplasms</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Plasma cell neoplasms and variants</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>A. PLASMA CELL NEOPLASMS</strong></td>\n</tr>\n<tr>\n<td><strong> Multiple myeloma </strong>(previously plasma cell myeloma)</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Non secretory: No secretion of Ig, No M component</li>\n<li>Smoldering: M protein in serum ≥ 3g/dL and/or ≥10% clonal plasma cells in bone marrow, and no related organ or tissue impairment</li>\n<li>Plasma-cell leukemia: &gt;20% plasma cells in the peripheral blood or Absolute plasma cell count of &gt;2 X 109/L</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Plasmacytoma</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Solitary plasmacytoma: Localized tumour of monoclonal plasma cells with no clinical features of plasma cell myeloma</li>\n<li>Extramedullary(extraosseous) plasmacytoma: Localized plasma cell neoplasms that arise in tissues other than bone</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Plasma cell neoplasms with associated paraneoplastic syndrome </strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>POEMS syndrome- Polyneuropathy, organomegaly, Endocrinopathy, Monoclonal gammopathy, Skin changes</li>\n<li>TEMPI syndrome </li>\n<li>AESOP syndrome</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>B. MONOCLONAL IMMUNOGLOBULIN DEPOSITION DISEASES </strong></td>\n</tr>\n<tr>\n<td><strong>Immunoglobulin-related</strong> (AL) <strong>amyloidosis</strong> (previously primary amyloidosis)</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Systemic AL amyloidosis</li>\n<li>Localised AL amyloidosis</li>\n<li>Heavy chain amyloidosis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Monoclonal immunoglobulin deposition disease</strong> (previously light and heavy chain deposition disease)</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Light chain deposition disease</li>\n<li>Heavy chain deposition disease</li>\n<li>Light and heavy chain deposition disease</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>C. MONOCLONAL GAMMOPATHIES</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Cold agglutinin disease</li>\n<li>Monoclonal gammopathy of renal significance</li>\n<li>IgM and non-IgM monoclonal gammopathy of undetermined signifcance</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9417",
      "difficulty": "easy"
    },
    {
      "text": "What is the most common cytogenetic abnormality in multiple myeloma?",
      "choices": [
        {
          "id": 1,
          "text": "Translocation 14q"
        },
        {
          "id": 2,
          "text": "Deletion of 13q"
        },
        {
          "id": 3,
          "text": "Translocation 11q"
        },
        {
          "id": 4,
          "text": "Deletion of 17p"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The<strong> most common</strong> cytogenetic abnormality in <strong>multiple myeloma</strong> is<strong> translocation 14q</strong>.</p>\n<p>Cytogenetic abnormalities in multiple myeloma include:</p>\n<ul>\n<li><strong>Translocations</strong> involving IGH on <strong>chromosome 14q</strong> - <strong>most frequent</strong> </li>\n<li>Monosomy or partial deletion of chromosome 13 (13q14) - Found by FISH (nearly half the cases)</li>\n<li>Translocation of the IgH occurs frequently with cyclin D1 on chromosome 11q and cyclin D3 on chromosome 6p</li>\n<li>Deletions of chromosome 17p involving TP53 tumor-suppressor locus</li>\n</ul>\n<p>Translocations with cyclin D1 are associated with a good outcome, whereas deletion of 17p and t(4;14) portend an aggressive course.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0205",
      "difficulty": "medium"
    },
    {
      "text": "Which cytokine is an important growth factor for plasma cells in multiple myeloma?",
      "choices": [
        {
          "id": 1,
          "text": "IL-2"
        },
        {
          "id": 2,
          "text": "IL-6"
        },
        {
          "id": 3,
          "text": "Interferon  γ"
        },
        {
          "id": 4,
          "text": "IL-1"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The proliferation and survival of <strong>plasma cells</strong> are dependent on several cytokines, most notably <strong>IL-6<em>.</em></strong></p>\n<p>It is an important growth factor for plasma cells. It is produced by the tumor cells themselves and by resident marrow stromal cells. IL6, along with other cytokines,&nbsp;<strong>promotes osteoclastic activity </strong>and<strong> lytic bone lesions.&nbsp;High</strong> serum levels of IL-6 are seen in patients with active disease&nbsp;and are associated with a<strong> poor prognosis</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9431",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is the most common monoclonal immunoglobulin seen in patients with myeloma?",
      "choices": [
        {
          "id": 1,
          "text": "IgM"
        },
        {
          "id": 2,
          "text": "IgA"
        },
        {
          "id": 3,
          "text": "IgE"
        },
        {
          "id": 4,
          "text": "IgG"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The most common <strong>monoclonal Ig</strong> (M protein) in <strong>myeloma</strong> is <strong>IgG</strong> (approximately 55% of patients), followed by IgA (approximately 25% of cases).</p>\n<p>The immunosecretory disorders are a diverse group of diseases associated with the proliferation of an<strong> abnormal clone</strong> of immunoglobulin-synthesizing, terminally differentiated B cells. These disorders include:</p>\n<ul>\n<li>Multiple myeloma (MM) and its variants</li>\n<li>Plasmacytoma</li>\n<li>Waldenstrom macroglobulinemia</li>\n<li>Monoclonal gammopathy of undetermined significance</li>\n<li>Monoclonal Ig deposition diseases - Includes primary amyloidosis and nonamyloidotic types.</li>\n</ul>\n<p>The immunoglobulin can be complete or can be composed of either heavy or light chains and is termed<strong> M-(monoclonal) protein.&nbsp;</strong>Most <strong>myelomas</strong> are associated with<strong> more than 3 gm/dL</strong> of serum immunoglobulin.&nbsp;Myelomas expressing IgM, IgD, or IgE occur, but they are rare.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9426",
      "difficulty": "easy"
    },
    {
      "text": "In patients with multiple myeloma, lytic lesions are most commonly seen in which bone?",
      "choices": [
        {
          "id": 1,
          "text": "Skull"
        },
        {
          "id": 2,
          "text": "Ribs"
        },
        {
          "id": 3,
          "text": "Pelvis"
        },
        {
          "id": 4,
          "text": "Vertebrae"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Lytic bony lesions</strong> in myeloma patients are most commonly seen in the<strong> vertebrae</strong>.</p>\n<p><strong>Multiple myeloma</strong> usually presents as destructive plasma cell tumors involving the axial skeleton. The bones most commonly affected (in<strong> descending order</strong> of frequency) are:</p>\n<ol>\n<li><strong>Vertebral column</strong></li>\n<li>Ribs</li>\n<li>Skull</li>\n<li>Pelvis</li>\n<li>Femur</li>\n<li>Clavicle</li>\n<li>Scapula</li>\n</ol>\n<p>Pathologic fractures are common in this condition. The bone lesions appear radiographically as<strong> punched-out defects, </strong>usually 1 to 4 cm in diameter.</p>\n<p>The image given below shows osteoblastic lesions of vertebra in multiple myeloma.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1826aaa0c79d44bdb257c20c68d9af90x513x1066.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9424",
      "difficulty": "easy"
    },
    {
      "text": "Which substance is responsible for the marked increase in bone resorption and hypercalcemia in patients with multiple myeloma?",
      "choices": [
        {
          "id": 1,
          "text": "IL 6"
        },
        {
          "id": 2,
          "text": "MIP 1α"
        },
        {
          "id": 3,
          "text": "NF- κB"
        },
        {
          "id": 4,
          "text": "ALP"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>MIP1&alpha;</strong> secreted by myeloma cells is responsible for the marked<strong> increase</strong> in<strong> bone resorption </strong>and <strong>hypercalcemia.</strong></p>\n<p>Factors produced by neoplastic plasma cells mediate bone destruction, the major pathologic feature of multiple myeloma. Of particular importance, myeloma-derived<strong>&nbsp;macrophage inflammatory protein 1&alpha;</strong> (MIP1&alpha;) upregulates the expression of the receptor activator of NF-&kappa;B ligand (<strong>RANKL</strong>) by bone marrow stromal cells, which in turn <strong>activates osteoclasts</strong>.</p>\n<p>Other factors released from tumor cells, such as modulators of the<strong> Wnt pathway</strong>, are potent<strong> inhibitors of osteoblast function</strong>.</p>\n<p>The net effect is a marked increase in bone resorption, which leads to <strong>hypercalcemia </strong>and <strong>pathological fractures</strong>.</p>\n<p>Serum<strong> alkaline phosphate </strong>levels are <strong>normal </strong>in multiple myeloma.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0204",
      "difficulty": "medium"
    },
    {
      "text": "A pathologist observed the following finding in a peripheral blood smear. In patients with which of the following conditions is this seen?<div class='question-desc-html'><ol>\n<li>Early HIV</li>\n<li>SLE</li>\n<li>Mycosis fungoides</li>\n<li>Hodgkin's lymphoma</li>\n<li>Multiple myeloma</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1 and 4 only"
        },
        {
          "id": 2,
          "text": "2, 3, and 5"
        },
        {
          "id": 3,
          "text": "1, 2, and 5"
        },
        {
          "id": 4,
          "text": "3 and 4 only"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given peripheral smear shows <strong>rouleaux</strong> formation. It is seen in patients with early HIV, SLE, and multiple myeloma.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5b57601f543543e0b85576198349c001x1280x1154.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ec064845202b4751a97571f70b50cae1x1280x1154.JPEG\" alt=\"Explanation Image\"><p><strong>Conditions</strong> that cause rouleaux formation are:</p>\n<ul>\n<li><strong>Multiple myeloma</strong></li>\n<li>Connective tissue disorders like <strong>SLE</strong></li>\n<li><strong>Early HIV</strong></li>\n<li>Infections</li>\n</ul>\n<p>Rouleaux formation is <strong>retarded by albumin</strong>.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/3c9b0ece8a97408a81fb7622d52988e5.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9428",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is least likely to be seen in patients with multiple myeloma?",
      "choices": [
        {
          "id": 1,
          "text": "Dutcher bodies"
        },
        {
          "id": 2,
          "text": "Russell bodies"
        },
        {
          "id": 3,
          "text": "Mooser bodies"
        },
        {
          "id": 4,
          "text": "Mott cells"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Mooser bodies are seen in Typhus fever, not in multiple myeloma.</p>\n<p>Histopathological findings seen in multiple myeloma:</p>\n<ul>\n<li><strong>Dutcher bodies -</strong>&nbsp;pale-staining <strong>intranuclear inclusions</strong> within plasma cells containing Ig, which are more common in <strong>IgA myeloma </strong>(Image below).&nbsp;</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/bd0de03fccda495182f36771da164273x1280x1153.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/db67ce9ac86648bf911efb2ef4655ce0x1280x1152.JPEG\" alt=\"Explanation Image\"><ul>\n<li><strong>Russell bodies</strong> -&nbsp;Hyaline intracytoplasmic inclusions containing Ig</li>\n<li><strong>Mott cells/ morula cells </strong>-&nbsp;Plasma cells containing multiple grape-like cytoplasmic inclusions comprised of Ig</li>\n<li><strong>Flame cells</strong> -&nbsp;Vermillion-staining, glycogen-rich IgA in cytoplasmic projections</li>\n<li><strong>Thesaurocytes </strong>-&nbsp;Dilated endoplasmic reticulum cisternae</li>\n</ul><hr><h3>Related Pearl: Pathological Cells/Bodies in Multiple Myeloma</h3><ul>\n<li><strong>Dutcher bodies -</strong>&nbsp;pale-staining, PAS-positive&nbsp;<strong>intranuclear inclusions</strong> within plasma cells containing Ig, which are more common in <strong>IgA myeloma </strong>(Image below).&nbsp;</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/97ef33b0c64f414f9c6629a62fe310bax1279x1152.JPEG\" alt=\"Pearl Image\"><p><strong>Russell bodies -&nbsp;</strong>They are globular intracellular accumulations of immunoglobulins (Ig). Russell bodies are distended endoplasmic reticulum. Plasma cells filled with multiple Russell bodies are called <strong>Mott cells.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/be2826017fa044f9a0f46c9a305d9baex1279x1199.JPEG\" alt=\"Pearl Image\"><ul>\n<li><strong>Flame cells</strong> - Plasma cells with fiery red cytoplasm due to vermillion-staining, glycogen-rich IgA in cytoplasmic projections</li>\n</ul><hr><h3>Related Pearl: Pathological Named Bodies</h3><table>\n<tbody>\n<tr>\n<td><strong>Bodies</strong></td>\n<td><strong>Found in</strong></td>\n</tr>\n<tr>\n<td>Asteroid bodies</td>\n<td>Sarcoidosis, Sporotrichosis</td>\n</tr>\n<tr>\n<td>\n<p>Halberstaedter&ndash;Prowazek bodies</p>\n</td>\n<td>Trachoma&nbsp;</td>\n</tr>\n<tr>\n<td>Miyagawa bodies</td>\n<td>Lymphogranuloma venereum&nbsp;</td>\n</tr>\n<tr>\n<td>Levinthal&ndash;Cole&ndash;Lillie bodies</td>\n<td>Psittacosis</td>\n</tr>\n<tr>\n<td>Leishman&ndash;Donovan bodies</td>\n<td>Kala-azar&nbsp;</td>\n</tr>\n<tr>\n<td>Negri bodies</td>\n<td>Rabies</td>\n</tr>\n<tr>\n<td>Guarnieri bodies</td>\n<td>Vaccinia</td>\n</tr>\n<tr>\n<td>Bollinger bodies</td>\n<td>Fowl pox</td>\n</tr>\n<tr>\n<td>Henderson&ndash;Paterson bodies</td>\n<td>Molluscum contagiosum&nbsp;</td>\n</tr>\n<tr>\n<td>Cowdry type-A bodies</td>\n<td>Yellow fever, Herpes virus infection&nbsp;</td>\n</tr>\n<tr>\n<td>Cowdry type-B bodies</td>\n<td>Adenovirus, poliovirus</td>\n</tr>\n<tr>\n<td>Rusell bodies</td>\n<td>Multiple myeloma&nbsp;</td>\n</tr>\n<tr>\n<td>Aschoff bodies</td>\n<td>Rheumatic fever&nbsp;</td>\n</tr>\n<tr>\n<td>Call&ndash;Exner bodies</td>\n<td>Granulosa cell tumor of the&nbsp;ovary&nbsp;</td>\n</tr>\n<tr>\n<td>Civatte (colloid) bodies</td>\n<td>Lichen planus&nbsp;</td>\n</tr>\n<tr>\n<td>Michaelis&ndash;Gutmann bodies</td>\n<td>Malakoplakia&nbsp;</td>\n</tr>\n<tr>\n<td>Lewy bodies</td>\n<td>Parkinson's disease&nbsp;</td>\n</tr>\n<tr>\n<td>Pappenheimer bodies</td>\n<td>Non-heme iron pigments in siderocytes&nbsp;</td>\n</tr>\n<tr>\n<td>Howell&ndash;Jolly bodies</td>\n<td>Splenectomy, Megaloblastic Anemia, Hemolytic anemia&nbsp;</td>\n</tr>\n<tr>\n<td>Heinz bodies</td>\n<td>G-6-PD deficiency&nbsp;</td>\n</tr>\n<tr>\n<td>Gamna&ndash;Gandy bodies</td>\n<td>Congestive splenomegaly&nbsp;</td>\n</tr>\n<tr>\n<td>Mallory bodies</td>\n<td>Hyaline inclusions in hepatocytes seen in alcoholic cirrhosis, Indian childhood cirrhosis</td>\n</tr>\n<tr>\n<td>Councilman bodies</td>\n<td>Hepatocytes undergoing apoptosis,&nbsp;seen mainly in acute viral hepatitis.</td>\n</tr>\n<tr>\n<td>Psammoma bodies</td>\n<td>Dystrophic calcification in meningioma, papillary serous cystadenoma of ovary &amp; papillary carcinoma of thyroid, papillary type of renal cell carcinoma.</td>\n</tr>\n<tr>\n<td>Donovan bodies</td>\n<td>Granuloma inguinale&nbsp;</td>\n</tr>\n<tr>\n<td>Nissl's bodies</td>\n<td>Cytoplasmic inclusions in neurons&nbsp;</td>\n</tr>\n<tr>\n<td>Mooser bodies</td>\n<td>Typhus fever</td>\n</tr>\n<tr>\n<td>Creola bodies</td>\n<td>Asthma&nbsp;</td>\n</tr>\n<tr>\n<td>Verocay bodies</td>\n<td>Schwannoma&nbsp;</td>\n</tr>\n<tr>\n<td>Schiller&ndash;Duval bodies</td>\n<td>Endodermal sinus tumor&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Hirano bodies</p>\n</td>\n<td>&nbsp;Alzheimer&rsquo;s disease</td>\n</tr>\n<tr>\n<td>\n<p>Ferruginous bodies</p>\n</td>\n<td>Asbestosis&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9430",
      "difficulty": "easy"
    },
    {
      "text": "The peripheral smear of a patient diagnosed with multiple myeloma is shown below. What does the marked structure contain?",
      "choices": [
        {
          "id": 1,
          "text": "Immunoglobulin"
        },
        {
          "id": 2,
          "text": "Golgi bodies"
        },
        {
          "id": 3,
          "text": "Rough endoplasmic reticulum"
        },
        {
          "id": 4,
          "text": "Apoptotic bodies"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given image shows<strong>&nbsp;</strong>a <strong>Mott cell</strong>&nbsp;which is a plasma cell with globular&nbsp;<strong>cytoplasmic inclusions</strong> containing <strong>immunoglobulins</strong> called <strong>Russell bodies</strong>.</p>\n<p><strong>Inclusions containing Ig </strong>are frequently seen in the cytoplasm (<strong>Russell bodies</strong>) or the nucleus (<strong>Dutcher bodies</strong>) of some of the plasma cells in myeloma.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6f94b54944444fdbb52f27bd1990aed5x1280x1199.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f08df38011214369800be6225b1eb85ex1280x1199.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Pathological Cells/Bodies in Multiple Myeloma</h3><ul>\n<li><strong>Dutcher bodies -</strong>&nbsp;pale-staining, PAS-positive&nbsp;<strong>intranuclear inclusions</strong> within plasma cells containing Ig, which are more common in <strong>IgA myeloma </strong>(Image below).&nbsp;</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/97ef33b0c64f414f9c6629a62fe310bax1279x1152.JPEG\" alt=\"Pearl Image\"><p><strong>Russell bodies -&nbsp;</strong>They are globular intracellular accumulations of immunoglobulins (Ig). Russell bodies are distended endoplasmic reticulum. Plasma cells filled with multiple Russell bodies are called <strong>Mott cells.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/be2826017fa044f9a0f46c9a305d9baex1279x1199.JPEG\" alt=\"Pearl Image\"><ul>\n<li><strong>Flame cells</strong> - Plasma cells with fiery red cytoplasm due to vermillion-staining, glycogen-rich IgA in cytoplasmic projections</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/53bcf73b43c6498d95fcba32fdb02b7a.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9462",
      "difficulty": "medium"
    },
    {
      "text": "The marked finding in plasma cells is due to:",
      "choices": [
        {
          "id": 1,
          "text": "Lysosomes"
        },
        {
          "id": 2,
          "text": "Golgi apparatus"
        },
        {
          "id": 3,
          "text": "Ig deposits"
        },
        {
          "id": 4,
          "text": "Cytoplasmic vacuole"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The marked finding is <strong>perinuclear hof</strong>&nbsp;(perinuclear clearing) in plasma cells. It occurs due to a prominent <strong>Golgi apparatus</strong>.</p>\n<p>Plasma cell characteristics include:</p>\n<ul>\n<li>Eccentric nuclei</li>\n<li>Moderate to abundant basophilic cytoplasm</li>\n<li>Pale perinuclear hof, representing the Golgi zone&nbsp;</li>\n</ul>\n<p>The image given below shows plasma cells with perinuclear hof.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fa50ee90c14c4be48a6b2388cc107f9dx1280x1151.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/77d91bfc5c374212a67c8aca4ff6e977.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0206",
      "difficulty": "hard"
    },
    {
      "text": "A 60-year-old male presented with a history of intractable diarrhea. Based on the histological image shown below which of the following is the most appropriate diagnosis:",
      "choices": [
        {
          "id": 1,
          "text": "Lymphoma"
        },
        {
          "id": 2,
          "text": "Leishmaniasis"
        },
        {
          "id": 3,
          "text": "Urate nephropathy"
        },
        {
          "id": 4,
          "text": "Multiple myeloma"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical scenario points to the diagnosis of<strong> multiple myeloma</strong>. </p>\n<p>The image shows<strong> Russell bodies</strong> which are eosinophilic, large, homogeneous immunoglobulin-containing inclusions usually found in a plasma cell undergoing excessive synthesis of immunoglobulins. Russell bodies are distended endoplasmic reticulum.</p>\n<p><strong>Globular inclusions </strong>are<strong> Russell bodies </strong>(if cytoplasmic) and<strong> Dutcher bodies </strong>(if nuclear). </p>\n<p>The below image shows Russell bodies:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7d2b8cf60e5b488783d68294f57b1b18x720x545.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Pathological Cells/Bodies in Multiple Myeloma</h3><ul>\n<li><strong>Dutcher bodies -</strong>&nbsp;pale-staining, PAS-positive&nbsp;<strong>intranuclear inclusions</strong> within plasma cells containing Ig, which are more common in <strong>IgA myeloma </strong>(Image below).&nbsp;</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/97ef33b0c64f414f9c6629a62fe310bax1279x1152.JPEG\" alt=\"Pearl Image\"><p><strong>Russell bodies -&nbsp;</strong>They are globular intracellular accumulations of immunoglobulins (Ig). Russell bodies are distended endoplasmic reticulum. Plasma cells filled with multiple Russell bodies are called <strong>Mott cells.</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/be2826017fa044f9a0f46c9a305d9baex1279x1199.JPEG\" alt=\"Pearl Image\"><ul>\n<li><strong>Flame cells</strong> - Plasma cells with fiery red cytoplasm due to vermillion-staining, glycogen-rich IgA in cytoplasmic projections</li>\n</ul><hr><h3>Related Pearl: Pathological Named Bodies</h3><table>\n<tbody>\n<tr>\n<td><strong>Bodies</strong></td>\n<td><strong>Found in</strong></td>\n</tr>\n<tr>\n<td>Asteroid bodies</td>\n<td>Sarcoidosis, Sporotrichosis</td>\n</tr>\n<tr>\n<td>\n<p>Halberstaedter&ndash;Prowazek bodies</p>\n</td>\n<td>Trachoma&nbsp;</td>\n</tr>\n<tr>\n<td>Miyagawa bodies</td>\n<td>Lymphogranuloma venereum&nbsp;</td>\n</tr>\n<tr>\n<td>Levinthal&ndash;Cole&ndash;Lillie bodies</td>\n<td>Psittacosis</td>\n</tr>\n<tr>\n<td>Leishman&ndash;Donovan bodies</td>\n<td>Kala-azar&nbsp;</td>\n</tr>\n<tr>\n<td>Negri bodies</td>\n<td>Rabies</td>\n</tr>\n<tr>\n<td>Guarnieri bodies</td>\n<td>Vaccinia</td>\n</tr>\n<tr>\n<td>Bollinger bodies</td>\n<td>Fowl pox</td>\n</tr>\n<tr>\n<td>Henderson&ndash;Paterson bodies</td>\n<td>Molluscum contagiosum&nbsp;</td>\n</tr>\n<tr>\n<td>Cowdry type-A bodies</td>\n<td>Yellow fever, Herpes virus infection&nbsp;</td>\n</tr>\n<tr>\n<td>Cowdry type-B bodies</td>\n<td>Adenovirus, poliovirus</td>\n</tr>\n<tr>\n<td>Rusell bodies</td>\n<td>Multiple myeloma&nbsp;</td>\n</tr>\n<tr>\n<td>Aschoff bodies</td>\n<td>Rheumatic fever&nbsp;</td>\n</tr>\n<tr>\n<td>Call&ndash;Exner bodies</td>\n<td>Granulosa cell tumor of the&nbsp;ovary&nbsp;</td>\n</tr>\n<tr>\n<td>Civatte (colloid) bodies</td>\n<td>Lichen planus&nbsp;</td>\n</tr>\n<tr>\n<td>Michaelis&ndash;Gutmann bodies</td>\n<td>Malakoplakia&nbsp;</td>\n</tr>\n<tr>\n<td>Lewy bodies</td>\n<td>Parkinson's disease&nbsp;</td>\n</tr>\n<tr>\n<td>Pappenheimer bodies</td>\n<td>Non-heme iron pigments in siderocytes&nbsp;</td>\n</tr>\n<tr>\n<td>Howell&ndash;Jolly bodies</td>\n<td>Splenectomy, Megaloblastic Anemia, Hemolytic anemia&nbsp;</td>\n</tr>\n<tr>\n<td>Heinz bodies</td>\n<td>G-6-PD deficiency&nbsp;</td>\n</tr>\n<tr>\n<td>Gamna&ndash;Gandy bodies</td>\n<td>Congestive splenomegaly&nbsp;</td>\n</tr>\n<tr>\n<td>Mallory bodies</td>\n<td>Hyaline inclusions in hepatocytes seen in alcoholic cirrhosis, Indian childhood cirrhosis</td>\n</tr>\n<tr>\n<td>Councilman bodies</td>\n<td>Hepatocytes undergoing apoptosis,&nbsp;seen mainly in acute viral hepatitis.</td>\n</tr>\n<tr>\n<td>Psammoma bodies</td>\n<td>Dystrophic calcification in meningioma, papillary serous cystadenoma of ovary &amp; papillary carcinoma of thyroid, papillary type of renal cell carcinoma.</td>\n</tr>\n<tr>\n<td>Donovan bodies</td>\n<td>Granuloma inguinale&nbsp;</td>\n</tr>\n<tr>\n<td>Nissl's bodies</td>\n<td>Cytoplasmic inclusions in neurons&nbsp;</td>\n</tr>\n<tr>\n<td>Mooser bodies</td>\n<td>Typhus fever</td>\n</tr>\n<tr>\n<td>Creola bodies</td>\n<td>Asthma&nbsp;</td>\n</tr>\n<tr>\n<td>Verocay bodies</td>\n<td>Schwannoma&nbsp;</td>\n</tr>\n<tr>\n<td>Schiller&ndash;Duval bodies</td>\n<td>Endodermal sinus tumor&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>Hirano bodies</p>\n</td>\n<td>&nbsp;Alzheimer&rsquo;s disease</td>\n</tr>\n<tr>\n<td>\n<p>Ferruginous bodies</p>\n</td>\n<td>Asbestosis&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/62bf0b4c0f354aec96124f0f77319754.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9449",
      "difficulty": "medium"
    },
    {
      "text": "A patient with pallor and pathological fracture is diagnosed with multiple myeloma. Which of the following is not a kidney finding of such patients?",
      "choices": [
        {
          "id": 1,
          "text": "Tubular casts"
        },
        {
          "id": 2,
          "text": "Nephrocalcinosis"
        },
        {
          "id": 3,
          "text": "Wire-loop lesions"
        },
        {
          "id": 4,
          "text": "Renal tubular necrosis"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Wire-loop lesions</strong> are seen in<strong> systemic lupus erythematosus</strong>&nbsp;and not in multiple myeloma.&nbsp;</p>\n<p><strong>Renal insufficiency</strong> occurs in half the patients with<strong> multiple myeloma</strong> and several factors are responsible for it. They develop acute kidney injury with ologuria and chronic kidney disease. Tubular casts, amyloidosis, and renal tubular necrosis are all described in the myeloma kidneys.</p>\n<p>Features of<strong> myeloma kidney</strong>:&nbsp;</p>\n<ul>\n<li><strong>Bence&ndash;Jones proteinuria</strong> and<strong> cast nephropathy -</strong>&nbsp;The main cause of renal dysfunction is related to <strong>Bence&ndash;Jones </strong>(light-chain)<strong> proteinuria.&nbsp;</strong>Ig light chains are directly toxic to epithelial cells. Bence-Jones proteins form large, histologically distinct tubular casts that obstruct the tubular lumens and induce a characteristic inflammatory reaction (light-chain cast nephropathy).</li>\n<li><strong>Amyloidosis</strong> of AL type, formed from free light chains (usually of &lambda; type)</li>\n<li><strong>Light-chain deposition disease -</strong>&nbsp;light chains (usually of &kappa; type) deposit in the glomerular basement membrane and mesangium causing a glomerulopathy and in tubular basement membranes, which may cause tubulointerstitial nephritis.</li>\n<li><strong>Hypercalcemia -</strong>&nbsp;Nephrocalcinosis</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9441",
      "difficulty": "medium"
    },
    {
      "text": "What do Bence Jones proteins in the urine of multiple myeloma patients represent?",
      "choices": [
        {
          "id": 1,
          "text": "Light chains"
        },
        {
          "id": 2,
          "text": "Heavy chains"
        },
        {
          "id": 3,
          "text": "Intact antibodies"
        },
        {
          "id": 4,
          "text": "Part of heavy chains"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Bence Jones proteins</strong> are immunoglobulin <strong>light chains</strong> (paraproteins) produced by neoplastic plasma cells.</p>\n<p>They can be<strong> kappa </strong>(most of the time) or<strong> lambda.&nbsp;</strong>The light chains can be immunoglobulin fragments or single homogeneous immunoglobulins. In patients with plasma cell tumors, the level of free light chains is usually elevated. One of the light chains is elevated with a reduction in the other.&nbsp;<strong>Free light chains</strong> are excreted in the<strong> urine</strong> because they are small in size, where they are referred to as <strong>Bence Jones proteins.&nbsp;</strong>Tests for Bence Jones protein are:</p>\n<ul>\n<li>Heat test</li>\n<li>Urine protein electrophoresis</li>\n<li>Immunofixation</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9440",
      "difficulty": "easy"
    },
    {
      "text": "Hyperviscosity symptoms in patients with multiple myeloma occur due to which of the following types of M protein?",
      "choices": [
        {
          "id": 1,
          "text": "IgG1"
        },
        {
          "id": 2,
          "text": "IgG2"
        },
        {
          "id": 3,
          "text": "IgG3"
        },
        {
          "id": 4,
          "text": "IgG4"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Symptoms related to <strong>hyperviscosity </strong>in<strong> multiple myeloma</strong> occurs due to excessive production of M proteins, usually of <strong>IgG<sub>3</sub> or IgA</strong> subtype.</p>\n<p><strong>Waldenstrom macroglobulinemia (IgM myeloma)</strong> is the most common cause for hyperviscosity syndrome due to excess IgM paraprotein. Less commonly, it also occurs in <strong>multiple myeloma</strong> (with myeloma proteins <strong>IgA and IgG<sub>3</sub> types</strong>) and connective tissue diseases.</p>\n<p>Normal relative serum viscosity ranges from 1.4 to 1.8 units. Symptoms are not seen at &lt;4, and hyperviscosity syndrome typically requires a viscosity of &gt;5 units.</p>\n<p>Clinical features include:</p>\n<ul>\n<li>Visual impairment</li>\n<li>Neurologic problems</li>\n<li>Bleeding</li>\n<li>Cryoglobulinemia</li>\n</ul>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0208",
      "difficulty": "hard"
    },
    {
      "text": "Multiple myeloma patients associated with which type of M protein has the highest risk of renal insufficiency?",
      "choices": [
        {
          "id": 1,
          "text": "IgM"
        },
        {
          "id": 2,
          "text": "IgG"
        },
        {
          "id": 3,
          "text": "IgA"
        },
        {
          "id": 4,
          "text": "IgD"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>IgD type</strong> of multiple myeloma has the <strong>highest risk</strong>&nbsp;of<strong> renal insufficiency.</strong></p>\n<p>IgG is most commonly involved in multiple myeloma. The higher the level of IgG, the more is the risk of renal failure in patients with multiple myeloma overall. But the rarer IgD predominant multiple myeloma has the highest risk of renal insufficiency when compared to other types.</p>\n<p>IgD type&nbsp;multiple myeloma is a rare type of multiple myeloma. In this condition, there is monoclonal IgD in serum.&nbsp;On serum electrophoresis, there is&nbsp;<strong>no or absent M spike.&nbsp;</strong>There is a higher incidence of <strong>extramedullary involvement, amyloidosis, proteinuria,</strong> and<strong> renal insufficiency</strong> in comparison to IgG or IgA type multiple myeloma. It has a poor prognosis.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0209",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following tumor markers is least likely to be positive in a patient with multiple myeloma?",
      "choices": [
        {
          "id": 1,
          "text": "CD 56"
        },
        {
          "id": 2,
          "text": "syndecan-1"
        },
        {
          "id": 3,
          "text": "CD 138"
        },
        {
          "id": 4,
          "text": "CD 21"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Plasma-cell tumors are least likely to show positivity for CD 21.</p>\n<p>They are positive for <strong>CD138</strong>, an adhesion molecule also known as <strong>syndecan-1</strong>, <strong>CD 38</strong>, and often express <strong>CD56</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0214",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not considered as a myeloma-defining event, according to the revised criteria for the diagnosis of multiple myeloma?",
      "choices": [
        {
          "id": 1,
          "text": "More than one focal lesionon MRI of 5 mm or more"
        },
        {
          "id": 2,
          "text": "60% or more clonal plasma cells on bone marrow examination"
        },
        {
          "id": 3,
          "text": "Biopsy proven plasmacytoma"
        },
        {
          "id": 4,
          "text": "Serum involved/uninvolved free light-chain ratio of 100 or greater"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Biopsy-proven plasmacytoma is <strong>not </strong>considered as a myeloma-defining event (MDE).</p>\n<p><strong>Revised International Myeloma Working Group criteria</strong> for the diagnosis of multiple myeloma:</p>\n<p>Clonal bone marrow <strong>plasma cells ≥10%</strong> (or) Biopsy-proven bony or extramedullary plasmacytoma.</p>\n<p><strong>                                                      AND</strong></p>\n<p><strong>Myeloma defining events </strong>(one or more):<strong> Evidence </strong>of <strong>end-organ damage</strong> attributable to the underlying plasma cell proliferative disorder, specifically-</p>\n<ul>\n<li>Hyper<strong>C</strong>alcemia: Serum calcium level &gt;1 mg/dL higher than the upper limit of normal or &gt;11 mg/dL</li>\n<li><strong>R</strong>enal insufficiency: Creatinine clearance &lt;40 mL/min or serum creatinine &gt;2 mg/dL</li>\n<li><strong>A</strong>nemia: Hemoglobin level of &gt;20 g/L (2gm/dl) below the lowest limit of normal, or Hb &lt;10 g/dL</li>\n<li><strong>B</strong>one lesions: One or more osteolytic lesions on skeletal radiography, computed tomography (CT), or positron emission tomography (PET)/CT.</li>\n<li>Any one or more <strong>biomarkers of malignancy</strong>: Clonal bone marrow plasma cells ≥60%; Serum involved/uninvolved free light-chain ratio ≥ 100; &gt;1 focal lesion on magnetic resonance imaging (MRI) that is ≥ 5 mm in size.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0200",
      "difficulty": "medium"
    },
    {
      "text": "A 60-year-old lady presents with complaints of pallor, recurrent UTI, and bone pain in lower limbs. Peripheral smear shows rouleaux formation.  X-ray done is given below. Which is the best immunohistochemical marker for this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Annexin A1"
        },
        {
          "id": 2,
          "text": "CD20"
        },
        {
          "id": 3,
          "text": "Cyclin D1"
        },
        {
          "id": 4,
          "text": "Hep-par 1"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario and X-ray showing lytic lesions on the bone are suggestive of <strong>multiple myeloma</strong>. The best<strong>&nbsp;immunohistochemical </strong>(IHC) marker for this condition&nbsp;is <strong>cyclin D1.</strong></p>\n<p>Multiple myeloma&nbsp;is associated with diverse translocations involving the <strong>IgH&nbsp;</strong>locus; overexpression of D cyclins&mdash;<strong>cyclin D1</strong> and D3. Plasma cell tumors are positive for <strong>CD138</strong> and often express <strong>CD56.</strong></p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/6b7adbe4cd134a48bd62c4c824e0a3fc.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0207",
      "difficulty": "medium"
    },
    {
      "text": "A patient diagnosed with multiple myeloma develops features of restrictive cardiomyopathy and macroglossia. Which of the following amyloid is responsible for this?",
      "choices": [
        {
          "id": 1,
          "text": "AL"
        },
        {
          "id": 2,
          "text": "AA"
        },
        {
          "id": 3,
          "text": "Aβ2m"
        },
        {
          "id": 4,
          "text": "A Cal"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario is suggestive of<strong> amyloidosis</strong>. The amyloid of the<strong> AL type</strong> is produced from free Ig light chains secreted by a monoclonal population of plasma cells and its deposition is associated with <strong>multiple myeloma.</strong></p><hr><h3>Related Pearl: Classification of Amyloidosis</h3><div class=\"page\" title=\"Page 270\">\n<table><colgroup><col /><col /><col /><col /> </colgroup>\n<tbody>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Clinicopathologic Category</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Major Fibril Protein</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Chemically Related Precursor Protein</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Systemic (Generalized) Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Immunoglobulin light chain amyloidosis (<strong>primary amyloidosis</strong>)</p>\n<p>Seen in Multiple myeloma and other monoclonal plasma cell proliferation</p>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AL</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Immunoglobulin light chains, chiefly &lambda; type</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Reactive systemic amyloidosis (<strong>secondary amyloidosis</strong>)</p>\n<p>Seen in chronic inflammatory conditions</p>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AA</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>SAA</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Hemodialysis-associated amyloidosis</p>\n<p>Seen in chronic renal failure</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A&beta;2m</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>&beta;2-microglobulin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Hereditary Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Familial Mediterranean fever</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AA</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>SAA</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Familial amyloidotic neuropathies</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>ATTR</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Mutated transthyretin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Systemic senile amyloidosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>ATTR</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Normal transthyretin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Localized Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Senile cerebral amyloidosis</p>\n<p>Seen in Alzheimer's disease</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A&beta;</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>APP</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Endocrine disorders like Type 2 diabetes</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Medullary carcinoma thyroid</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A Cal</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Calcitonin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Islets of Langerhans</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AIAPP</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Islet amyloid peptide</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Isolated atrial amyloidosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AANF</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Atrial natriuretic factor</p>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9444",
      "difficulty": "easy"
    },
    {
      "text": "What is the most common cause of death in patients with myeloma?",
      "choices": [
        {
          "id": 1,
          "text": "Renal failure"
        },
        {
          "id": 2,
          "text": "Infections"
        },
        {
          "id": 3,
          "text": "Cardiac failure"
        },
        {
          "id": 4,
          "text": "Hypercalcemic crisis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Infections</strong> are the most common <strong>cause of death</strong> in patients with <strong>myeloma</strong>.</p>\n<p>Complications of multiple myeloma include:</p>\n<ul>\n<li>Infections</li>\n<li>Renal failure</li>\n<li>Cardiac failure</li>\n<li>Hypercalcemia</li>\n<li>Anemia</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9432",
      "difficulty": "medium"
    },
    {
      "text": "A 60-year-old man presents with complaints of fatigue, pain over the ribs, and confusion. Lab investigations reveal anemia, hypercalcemia, and increased serum creatinine. X-ray shows lytic lesions on the bones. Which of the following is the most powerful prognostic indicator of this condition at the time of diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Number of myeloma cells in the marrow"
        },
        {
          "id": 2,
          "text": "β2 microglobulin"
        },
        {
          "id": 3,
          "text": "Serum C-reactive protein"
        },
        {
          "id": 4,
          "text": "Serum creatinine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario is suggestive of <strong>multiple myeloma.</strong> The <strong>most powerful </strong>prognostic indicator of this condition at the time of diagnosis is <strong>serum &beta;2 microglobulin</strong>.</p>\n<p>Beta-2 microglobulin is a <strong>low-molecular-weight</strong> protein found on the surface of all nucleated cells. It is the light chain of the HLA histocompatibility complex.</p><hr><h3>Related Pearl: Prognostic Factors in Myeloma</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Poor prognosis</strong></p>\n</td>\n<td>\n<p><strong>Good prognosis</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>t(4;14), MAF translocations t(14;16) and t(14;20), del(17p), aneuploidy, hypodiploidy</p>\n</td>\n<td>\n<p>Hyperdiploid, t(11;14), t(6;14), cyclin D1 or D3 positive</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Elevated beta-2 microglobulin, lactate dehydrogenase, C- reactive protein, plasma-cell proliferation, or bone marrow infiltration</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Plasmablastic morphology</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Abnormalities by conventional cytogenetics</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Plasma labelling index &gt;3%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Serum creatinine level &gt;2mg/dL</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Bone marrow biopsy: Diffuse&nbsp;and prominent angiogenesis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Low serum albumin</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: International Staging System (ISS) for multiple myeloma:</h3><p><strong>International Staging System (ISS) for multiple myeloma:</strong></p>\n<table>\n<tbody>\n<tr>\n<td>&beta;2 microglobulin (mg/dL) and albumin (g/dL) level</td>\n<td>Stage</td>\n<td>Median survival months</td>\n</tr>\n<tr>\n<td>\n<p>&beta;2M &lt; 3.5</p>\n<p>alb&nbsp;&ge;3.5</p>\n</td>\n<td>I</td>\n<td>62</td>\n</tr>\n<tr>\n<td>\n<p>&beta;2M &lt; 3.5, alb &lt; 3.5</p>\n<p>or&nbsp;&beta;2M = 3.5-5.5</p>\n</td>\n<td>II</td>\n<td>44</td>\n</tr>\n<tr>\n<td>&beta;2M &gt; 5.5</td>\n<td>III</td>\n<td>29</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>ISS is the most widely used method of assesing prognosis in multiple myeloma.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0211",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not associated with poor prognosis in a patient with multiple myeloma?",
      "choices": [
        {
          "id": 1,
          "text": "t(4;14)"
        },
        {
          "id": 2,
          "text": "High serum beta-2 microglobulin"
        },
        {
          "id": 3,
          "text": "Low serum albumin"
        },
        {
          "id": 4,
          "text": "t(11;14)"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>t(11;14)</strong> is associated with a<strong> good prognosis</strong> in patients with myeloma.</p>\n<p>t(4;14), <strong>high serum beta-2 microglobulin</strong>, and low serum albumin are all <strong>poor prognostic factors</strong> in myeloma.</p><hr><h3>Related Pearl: Prognostic Factors in Myeloma</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Poor prognosis</strong></p>\n</td>\n<td>\n<p><strong>Good prognosis</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>t(4;14), MAF translocations t(14;16) and t(14;20), del(17p), aneuploidy, hypodiploidy</p>\n</td>\n<td>\n<p>Hyperdiploid, t(11;14), t(6;14), cyclin D1 or D3 positive</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Elevated beta-2 microglobulin, lactate dehydrogenase, C- reactive protein, plasma-cell proliferation, or bone marrow infiltration</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Plasmablastic morphology</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Abnormalities by conventional cytogenetics</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Plasma labelling index &gt;3%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Serum creatinine level &gt;2mg/dL</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Bone marrow biopsy: Diffuse&nbsp;and prominent angiogenesis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Low serum albumin</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9436",
      "difficulty": "easy"
    },
    {
      "text": "A 70-year-old man presents with chronic low back pain. On examination, he has pallor and bony tenderness. A skeletal radiographic survey reveals several punched-out lytic lesions. Serum protein electrophoresis shows an M band in the gamma globulin region. Which of the following is not associated with a poor prognosis in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Translocation involving cyclin D1"
        },
        {
          "id": 2,
          "text": "t(14;16)"
        },
        {
          "id": 3,
          "text": "Deletions of 17p"
        },
        {
          "id": 4,
          "text": "t(14;20)"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario is highly suggestive of <strong>multiple myeloma</strong>. <strong>Translocations</strong> involving <strong>cyclin D1</strong> are associated with a <strong>good outcome</strong> in this condition.</p>\n<p>t(14;16), deletions of 17p, and t(14;20) are associated with a more aggressive course.</p><hr><h3>Related Pearl: Prognostic Factors in Myeloma</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Poor prognosis</strong></p>\n</td>\n<td>\n<p><strong>Good prognosis</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>t(4;14), MAF translocations t(14;16) and t(14;20), del(17p), aneuploidy, hypodiploidy</p>\n</td>\n<td>\n<p>Hyperdiploid, t(11;14), t(6;14), cyclin D1 or D3 positive</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Elevated beta-2 microglobulin, lactate dehydrogenase, C- reactive protein, plasma-cell proliferation, or bone marrow infiltration</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Plasmablastic morphology</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Abnormalities by conventional cytogenetics</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Plasma labelling index &gt;3%</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Serum creatinine level &gt;2mg/dL</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Bone marrow biopsy: Diffuse&nbsp;and prominent angiogenesis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Low serum albumin</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9434",
      "difficulty": "medium"
    },
    {
      "text": "Which among these is not diagnostic of monoclonal gammopathy of undetermined significance?",
      "choices": [
        {
          "id": 1,
          "text": "Serum M protein level < 3 g/dL"
        },
        {
          "id": 2,
          "text": "Bence-Jones proteins in urine"
        },
        {
          "id": 3,
          "text": "Bone marrow plasma cells <10%"
        },
        {
          "id": 4,
          "text": "Absence of lytic bone lesions"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Bence&ndash;Jones proteinuria</strong> is not diagnostic of monoclonal gammopathy of undetermined significance&nbsp;(MGUS) because it is seen in multiple myeloma also.</p>\n<p>MGUS is the most common monoclonal gammopathy.</p>\n<p>Diagnostic criteria of MGUS according to<strong> International Myeloma Working Group guidelines (2014):</strong></p>\n<ul>\n<li>Serum monoclonal protein &lt;3g/dL</li>\n<li>Clonal bone marrow plasma cells &lt; 10%</li>\n<li>Absence of end-organ damage such as hyper<strong>c</strong>alcemia, <strong>r</strong>enal failure, <strong>a</strong>nemia and <strong>b</strong>one lesions (<strong>CRAB</strong>)</li>\n<li>No amyloidosis</li>\n</ul>\n<p>The three distinct <strong>clinical types of MGUS </strong>are:</p>\n<ul>\n<li><strong>Non-IgM MGUS</strong>:\n<ul>\n<li>Most common subtype of MGUS</li>\n<li>Approximately 1% of patients with MGUS develop a symptomatic plasma cell neoplasm, usually multiple myeloma, per year</li>\n</ul>\n</li>\n<li><strong>IgM MGUS</strong>:\n<ul>\n<li>IgM MGUS accounts for approximately 15% of MGUS cases</li>\n<li>It can progress to Waldenstr&ouml;m macroglobulinemia, but progression to multiple myeloma is rare</li>\n<li>Bence&ndash;Jones proteinuria has been reported in approximately 20% of these cases</li>\n</ul>\n</li>\n<li><strong>Light chain MGUS (LC-MGUS)</strong>:\n<ul>\n<li>LC-MGUS is a unique subtype of MGUS in which there is no immunoglobulin heavy-chain component</li>\n<li>Urinary M protein &lt;500 mg/24 hour</li>\n<li>LC-MGUS may progress to light-chain smoldering multiple myeloma (idiopathic Bence&ndash;Jones proteinuria) and to light-chain multiple myeloma</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9447",
      "difficulty": "medium"
    },
    {
      "text": "A patient with complaints of blurred vision, bleeding gums, and tingling sensation over the extremities is diagnosed with lymphoplasmacytic lymphoma. Which of the following immunoglobulins is this condition associated with?",
      "choices": [
        {
          "id": 1,
          "text": "IgG"
        },
        {
          "id": 2,
          "text": "IgA"
        },
        {
          "id": 3,
          "text": "IgE"
        },
        {
          "id": 4,
          "text": "IgM"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>High levels of <strong>IgM</strong> are seen in<strong> lymphoplasmacytic lymphoma</strong>.</p>\n<p>In lymphoplasmacytic lymphoma, high levels of IgM lead to symptoms related to hyperviscosity of the blood. This is known as&nbsp;<strong>Waldenstrom&rsquo;s macroglobulinemia.&nbsp;</strong><em>&lsquo;</em>M&rsquo; or monoclonal spike is seen in this condition. Here, it is caused by IgM; in multiple myeloma, it is caused by IgG. It is characterized by the <strong>absence of lytic lesions</strong> and <strong>normal&nbsp;</strong><strong>serum calcium </strong>levels.</p>\n<p>IgM greatly increases the viscosity of the blood, giving rise to a hyperviscosity syndrome characterized by the following:</p>\n<ul>\n<li>Visual impairment</li>\n<li>Neurologic problems</li>\n<li>Bleeding</li>\n<li>Cryoglobulinemia</li>\n</ul>\n<p>The <strong>normal</strong> relative <strong>viscosity</strong> of the serum is <strong>1.8</strong>.</p>\n<p><strong>Hyperviscosity</strong> is seen in:</p>\n<ul>\n<li>Multiple myeloma</li>\n<li>Waldenstrom&rsquo;s macroglobulinemia</li>\n<li>Cryoglobulinemia</li>\n<li>Myeloproliferative disorders</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9449",
      "difficulty": "medium"
    },
    {
      "text": "A 40-year-old man is diagnosed with lymphoplasmacytic lymphoma. Which of the following genes is mutated in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "MYC"
        },
        {
          "id": 2,
          "text": "MYD88"
        },
        {
          "id": 3,
          "text": "SOX"
        },
        {
          "id": 4,
          "text": "RUNX1"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Virtually all cases of <strong>lymphoplasmacytic lymphoma</strong> are associated with acquired <strong>mutations </strong>in<strong> <em>MYD88</em></strong>.&nbsp;</p>\n<p>The&nbsp;<strong>most common </strong>cytogenetic abnormality associated with lymphoplasmacytic lymphoma is <strong>deletion of 6q</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0202",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is not seen in patients with Waldenstrom macroglobulinemia?",
      "choices": [
        {
          "id": 1,
          "text": "M spike in serum protein electrophoresis"
        },
        {
          "id": 2,
          "text": "Increased serum calcium"
        },
        {
          "id": 3,
          "text": "Features due to organ infiltration"
        },
        {
          "id": 4,
          "text": "Absence of lytic lesions on imaging"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Serum calcium</strong> levels remain<strong> normal</strong> in&nbsp;Waldenstr&ouml;m macroglobulinemia.</p>\n<p><strong>Waldenstr&ouml;m macroglobulinemia</strong>&nbsp;is a syndrome characterised by the following:</p>\n<ul>\n<li><strong>Hyperviscosity </strong>syndrome&nbsp;due to&nbsp;<strong>high levels of IgM</strong></li>\n<li>Most commonly occurs in association with lymphoplasmacytic lymphoma</li>\n<li><em>&lsquo;</em>M&rsquo; or monoclonal spike</li>\n<li><strong>Absence of lytic lesions</strong></li>\n<li><strong>Normal serum</strong> <strong>calcium</strong> levels</li>\n<li>Diffuse marrow infiltration by plasma cells, plasmacytoid lymphocytes, and lymphocytes (all from the same clone)</li>\n<li>Cells <strong>do not form tumor </strong>masses or produce lytic lesions</li>\n<li>Lymphocytes commonly contain <strong>Dutcher bodies (intranuclear inclusions)</strong></li>\n<li>Bence&ndash;Jones proteins in 20&ndash;30%</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9450",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is the most common site for extramedullary plasmacytoma?",
      "choices": [
        {
          "id": 1,
          "text": "Gastrointestinal system"
        },
        {
          "id": 2,
          "text": "Upper respiratory tract"
        },
        {
          "id": 3,
          "text": "Genitourinary system"
        },
        {
          "id": 4,
          "text": "Central nervous system"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Extramedullary plasmacytomas are seen in<strong> the upper respiratory tract</strong>.&nbsp;Most&nbsp;of them are seen in the nasopharynx, oropharynx, sinuses, and larynx.</p>\n<p><strong>Plasmacytoma</strong> is a tumor of plasma cells of bony or soft tissue. It can occur anywhere in the body without evidence of systemic disease.</p><hr><h3>Related Pearl: WHO Classification of Plasma Cell Neoplasms</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Plasma cell neoplasms and variants</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>A. PLASMA CELL NEOPLASMS</strong></td>\n</tr>\n<tr>\n<td><strong> Multiple myeloma </strong>(previously plasma cell myeloma)</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Non secretory: No secretion of Ig, No M component</li>\n<li>Smoldering: M protein in serum ≥ 3g/dL and/or ≥10% clonal plasma cells in bone marrow, and no related organ or tissue impairment</li>\n<li>Plasma-cell leukemia: &gt;20% plasma cells in the peripheral blood or Absolute plasma cell count of &gt;2 X 109/L</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Plasmacytoma</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Solitary plasmacytoma: Localized tumour of monoclonal plasma cells with no clinical features of plasma cell myeloma</li>\n<li>Extramedullary(extraosseous) plasmacytoma: Localized plasma cell neoplasms that arise in tissues other than bone</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Plasma cell neoplasms with associated paraneoplastic syndrome </strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>POEMS syndrome- Polyneuropathy, organomegaly, Endocrinopathy, Monoclonal gammopathy, Skin changes</li>\n<li>TEMPI syndrome </li>\n<li>AESOP syndrome</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>B. MONOCLONAL IMMUNOGLOBULIN DEPOSITION DISEASES </strong></td>\n</tr>\n<tr>\n<td><strong>Immunoglobulin-related</strong> (AL) <strong>amyloidosis</strong> (previously primary amyloidosis)</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Systemic AL amyloidosis</li>\n<li>Localised AL amyloidosis</li>\n<li>Heavy chain amyloidosis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Monoclonal immunoglobulin deposition disease</strong> (previously light and heavy chain deposition disease)</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Light chain deposition disease</li>\n<li>Heavy chain deposition disease</li>\n<li>Light and heavy chain deposition disease</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>C. MONOCLONAL GAMMOPATHIES</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Cold agglutinin disease</li>\n<li>Monoclonal gammopathy of renal significance</li>\n<li>IgM and non-IgM monoclonal gammopathy of undetermined signifcance</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9451",
      "difficulty": "hard"
    },
    {
      "text": "What is Seligmann's disease?",
      "choices": [
        {
          "id": 1,
          "text": "α- heavy chain disease"
        },
        {
          "id": 2,
          "text": "γ- heavy chain disease"
        },
        {
          "id": 3,
          "text": "μ- heavy chain disease"
        },
        {
          "id": 4,
          "text": "β- heavy chain disease"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>&alpha;- heavy</strong> chain disease (HCD) is known as <strong>Seligmann's disease</strong>.</p>\n<p>There are three heavy chain diseases:</p>\n<ul>\n<li><strong>&alpha;- heavy</strong> chain disease -&nbsp; <strong>Seligmann's disease</strong></li>\n<li><strong>&gamma;- heavy</strong> chain disease -&nbsp;<strong>&nbsp;Franklin's disease</strong></li>\n<li><strong>&mu;- heavy</strong> chain disease - Associated with light-chain secretion (Bence&ndash;Jones proteinuria) in a few cases</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0212",
      "difficulty": "hard"
    },
    {
      "text": "A 60-year-old man presents with a history of bone pain, weakness, and loss of weight for 3 years. On examination, enlarged lymph nodes and organomegaly are noted. Peripheral smear shows 22% plasma cells, which are λ-chain restricted. Serum IgE level is elevated. X-ray image of the lumbar vertebra shows lytic punched-out lesions. What is the diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Multiple myeloma"
        },
        {
          "id": 2,
          "text": "Plasmacytoma"
        },
        {
          "id": 3,
          "text": "Lymphoplasmacytic lymphoma"
        },
        {
          "id": 4,
          "text": "Plasma cell leukemia"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical scenario points to the diagnosis of<strong> plasma cell leukemia</strong>. In this case, the peripheral blood smear shows <strong>22% of plasma cells </strong>and<strong> </strong>presents with <strong>organomegaly</strong>.</p>\n<p>Plasma cell leukemia is defined by the observation in blood of <strong>more than 20% clonal plasma cells</strong> by differential count of the leucocytes or by counting <strong>more than 2 × 10<sup>9</sup> per liter circulating clonal plasma cells. </strong>Plasma cell leukemia (PCL) is a <strong>rare and aggressive form</strong> of leukemia and plasma cell dyscrasia. PCL can be divided into primary PCL (PCL) and secondary PCL (sPCL) following previously diagnosed multiple myeloma (MM); the latter typically occurring at a late and advanced stage of MM.</p>\n<p>Patients with plasma cell leukemia are more likely to have <strong>extramedullary involvement of liver and spleen</strong>, causing organomegaly than in multiple myeloma. (Option A)</p><hr><h3>Related Pearl: WHO Classification of Plasma Cell Neoplasms</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Plasma cell neoplasms and variants</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>A. PLASMA CELL NEOPLASMS</strong></td>\n</tr>\n<tr>\n<td><strong> Multiple myeloma </strong>(previously plasma cell myeloma)</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Non secretory: No secretion of Ig, No M component</li>\n<li>Smoldering: M protein in serum ≥ 3g/dL and/or ≥10% clonal plasma cells in bone marrow, and no related organ or tissue impairment</li>\n<li>Plasma-cell leukemia: &gt;20% plasma cells in the peripheral blood or Absolute plasma cell count of &gt;2 X 109/L</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Plasmacytoma</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Solitary plasmacytoma: Localized tumour of monoclonal plasma cells with no clinical features of plasma cell myeloma</li>\n<li>Extramedullary(extraosseous) plasmacytoma: Localized plasma cell neoplasms that arise in tissues other than bone</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Plasma cell neoplasms with associated paraneoplastic syndrome </strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>POEMS syndrome- Polyneuropathy, organomegaly, Endocrinopathy, Monoclonal gammopathy, Skin changes</li>\n<li>TEMPI syndrome </li>\n<li>AESOP syndrome</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>B. MONOCLONAL IMMUNOGLOBULIN DEPOSITION DISEASES </strong></td>\n</tr>\n<tr>\n<td><strong>Immunoglobulin-related</strong> (AL) <strong>amyloidosis</strong> (previously primary amyloidosis)</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Systemic AL amyloidosis</li>\n<li>Localised AL amyloidosis</li>\n<li>Heavy chain amyloidosis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Monoclonal immunoglobulin deposition disease</strong> (previously light and heavy chain deposition disease)</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Light chain deposition disease</li>\n<li>Heavy chain deposition disease</li>\n<li>Light and heavy chain deposition disease</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>C. MONOCLONAL GAMMOPATHIES</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Cold agglutinin disease</li>\n<li>Monoclonal gammopathy of renal significance</li>\n<li>IgM and non-IgM monoclonal gammopathy of undetermined signifcance</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0213",
      "difficulty": "hard"
    }
  ]
}